Pulmonary Disease & Critical Care Medicine : University of Vermont

Skip to local navigation Skip to main content

Apply to UVM

Department of Medicine

Pulmonary Disease & Critical Care Medicine

Bio for Polly Parsons, M.D.

Polly Parsons, M.D.

Professor of Medicine, Pulmonary Medicine
Department of Medicine

Contact Information

E-mail: Polly.Parsons@vtmednet.org
Phone: 802-847-5451
Office Location: Fletcher 311, 111 Colchester Ave, Burlington, VT 05401

Postdoctoral Training

1978 - 1979 Intern, Internal Medicine University of Colorado Medical Center
1979 - 1981 Resident, Internal MedicineUniversity of Colorado Medical Center
1981 - 1982 Research Fellow National Jewish Hospital and Research Center
1982 - 1985 Fellow, Pulmonary Medicine University of Colorado Health Sciences Center

Education

1971 - 1975 Radcliffe College, Harvard University A.B., Biology (Magna cum laude)
1975 - 1978 University of Arizona M.D., College of Medicine

Academic Appointments

1985 - 1986 Instructor, Department of Medicine University of Colorado Health Sciences Center
1986 - 1992 Assistant Professor, Department of Medicine University of Colorado Health Sciences Center
1992 - 1999 Associate Professor, Department of Medicine University of Colorado Health Sciences Center
1999-2000 Professor, Department of Medicine University of Colorado Health Sciences Center
2000-present Professor, Department of Medicine University of Vermont

Publications

Deutschman C D, Ahrens T, Cairns CB, Sessler CN, Parsons PE for the Critical Care Societies Collaborative/USCIITG Task Force on Critical Care Research. Multi-Society Task Force for Critical Care Research: Key issues and Recommendations. Chest 2012;141:198-200,201-209; Am J Respir Crit Care Med 2012; 185: 96-102;. Am J Crit Care 2012; 21:12-14;. Crit Care Med 2012; 40:254-260.

Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, Thompson BT, Matthay; National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 39:711-717 2011 (epub ahead of print 1-28-2011).

Elliott CG and Parsons PE. Update in Pulmonary and Critical Care Medicine: Evidence Published in 2011. Annals of Internal Medicine (in press).

Caldwell E, Curtis JR, Heyland DK, Watkins TR, Martin JM, Parsons PE, Wurfel MM, Hallstrand TS, Sims KA, Neff MJ. A Phase II Randomized Placebo-Controlled Trial of Omega-3 Fatty Acids for the Treatment of Acute Lung Injury. Crit Care Med 39:1655-1662 2011 (epub ahead of print 3-17-2011).

Calfee CS, Thompson BT, Parsons PE, Ware LB, Matthay MA, Wong HR. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Crit Care Med. 2010 Jun;38(6):1436-41.PMID: 2038630.

To view more of Dr. Parsons' publications, please visit PubMed.